Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > 30 day trading average...
View:
Post by mercedesman on Aug 23, 2022 11:23am

30 day trading average...

...without doing the weighted average math...

....looks to be about .49 or .50

...Was happy to add some .40 and .405's today, albeit tiny amounts (so far)

Devlishly difficult to get the cheap ones.

Also hate to "average up"...but in the grand scheme I think the odds of approval (or else a takeout before FDA has their say) of both trick ponies is very high...just a matter of time.

MM
Comment by Accountprince on Aug 23, 2022 11:55am
MM - with the EAA approved, SAMI FDA approved and now SELLING, DIMI approved for all but home use (approval for home use is a when not if per Seto) just these alone would more than cover the average of $0.50 a share and much more - a ten bagger there on its own.  Not much risk but Huge upside. PMX approved in Canada and now has a Breakthrough Designation with the FDA allowing all ...more  
Comment by mercedesman on Aug 23, 2022 12:02pm
Well said AP Where else can you find such a high probablility of a 10+ bagger, in a basically growing (Dialysis and Sepsis) and Recession proof Industry (Medical equipment and diagnostics) ? I take your point on limited to no downside, although I suppose, with so few knowing the story, there is a small risk of another under-priced "grab" in the short-term. MM
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities